Japanese contract research organisation (CRO) Mediscience Planning has formed a partnership with CROs from South Korea and Taiwan in response to growing demand for pan-Asian clinical trials.

The other two partners are LSK Global Pharma Services, the Seoul-based CRO that recently entered into a strategic alliance with China’s Tigermed Consulting; and Pharmaceutical Research Associates Taiwan, the local subsidiary of US-based CRO PRA International.

The partnership between Mediscience, LSK and PRA Taiwan covers the joint management of multinational clinical trials in Asia as well as related services such as study monitoring and data management.